Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Remote Observational Study in Pediatric Participants With Early-Onset SCN2A-Developmental and Epileptic Encephalopathy

NCT05407727 is registered in ClinicalTrials.gov with Praxis Precision Medicines as lead sponsor.

NCT NCT05407727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05407727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Remote Observational Study in Pediatric Participants With Early-Onset SCN2A-Developmental and Epileptic Encephalopathy
Lead sponsor
Praxis Precision Medicines
Phase
Observational
Overall status
Completed
Start date
April 15, 2022
Completion date
March 31, 2023
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, scn2a-dee